At the Anxiety Disorders Research Center, Amy works as laboratory manager and research coordinator to Michelle Craske, Ph.D. Her research interests lie in exploring the cognitive, affective, and behavioral mechanisms that generate and maintain anxiety disorders, such as anxiety sensitivity, cognitive biases, and distress tolerance. Facilitated by translational research, Amy is interested in the pharmacological augmentation of fear extinction and integrative treatment strategies.
Natalie is the research coordinator for the TAD study and a new upcoming pharmocological study we will be initiating in 2014. She is interested in examining the efficacy of behavioral and novel treatments for anxiety disorders. In particular, she is interested in looking at how and why treatments are effective and what are the mechanisms of change.